A novel classification for local recurrence after surgical removal of renal cell cancer
Author(s) -
Takeshi Yuasa
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.199
Subject(s) - medicine , cancer , kidney cancer
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan Correspondence to: Takeshi Yuasa, MD, PhD. 3-8-31 Ariake, Tokyo 135-8550, Japan. Email: takeshi.yuasa@jfcr.or.jp. Provenance and Peer Review: This article was commissioned and reviewed by the Section Editor Dr. Xiao Li (Department of Urology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China). Comment on: Lee Z, Jegede OA, Haas NB, et al. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol 2020;203:684-9.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom